Pharmacological provocation and prevention of suicidal behaviour

References

• AVORN, J., EVERITT, D.E. & WEISS, S. (1986). Increased antidepressant use in patients prescribed beta-blockers. Journal of the American Medical Association, 255, 357-360.
   PubMed Web of Science ®Google Scholar
• BALDWIN, D.S. & SINCLAIR, J.M.A. (1997). Recurrent brief depression: `nasty, brutish and short’. In: D. BHUGRA & A. MUNRO (Eds), Troublesome disguises: underdiagnosed psychiatric syndromes (pp. 226-240. Oxford: Blackwell Scienti c.
   Google Scholar
• BALDWIN, D.S., BULLOCK, T., MONTGOMERY, D.B. et al. (1991). 5-HT re-uptake inhibitors, tricyclic antidepressants and suicidal behaviour. International Clinical Psychopharma-cology, 6, 49-55.
   PubMed Web of Science ®Google Scholar
• BALDWIN, D.S., FINEBERG, N.A. & MONTGOMERY, S.A. (1991). Fluoxetine, fluvoxamine and extrapyramidal tract disorders. International Clinical Psychopharmacology, 6, 51-58.
   PubMed Web of Science ®Google Scholar
• BEASLEY, C.M., DOMSEIF, B.E., BOSOMWORTH, J.C. et al. (1991). Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal, 303, 685-692.
   PubMed Web of Science ®Google Scholar
• BEAUMONT, G., BALDWIN, D.S. & LADER, M. (1996). A criticism of the practice of prescribing sub-therapeutic doses of antidepressants for the treatment of depression. Human Psychopharmacology, 11, 283-291.
   Google Scholar
• BUCKLEY, N.A., DAWSON, A.H., WHYTE, I.M. et al. (1994). Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. The Lancet, 343, 159-162.
   PubMed Web of Science ®Google Scholar
• BUCKLEY, N.A., DAWSON, A.H., WHYTE, I.M. et al. (1995). Relative toxicity of benzodiazepines in overdose. British Medical Journal, 310, 219-221.
   PubMed Web of Science ®Google Scholar
• CASSIDY, S.L. & HENRY, J.A. (1987). Fatal toxicity of antidepressant drugs in overdose. British Medical Journal, 295, 1021-1024.
   PubMed Web of Science ®Google Scholar
• COPPEN, A., STANDISH-BARRY, H., BAILEY, J. et al. (1991). Does lithium reduce the mortality of recurrent mood disorders? Journal of Affective Disorders, 23, 1-7.
   PubMed Web of Science ®Google Scholar
• CREANEY, W., MURRAY, I. & HEALY, D. (1991). Antidepres-sant induced suicidal ideation. Human Psychopharma-cology, 6, 329-332.
   Web of Science ®Google Scholar
• DAMLUJI, N.F. & FERGUSON, J.M. (1988). Paradoxical worsening of depressive symptoms caused by antidepres-sants.Journal of Clinical Psychopharmacology, 8, 347-349.
   PubMed Web of Science ®Google Scholar
• DEPARTMENT OF HEALTH (1992). The health of the nation: a strategy for health in England. London: HMSO.
   Google Scholar
• EDWARDS, J.G. (1995). Suicide and antidepressants. Controversies on prevention, provocation and self-poisoning continue. British Medical Journal, 310, 205-206.
   PubMed Web of Science ®Google Scholar
• ENGELBERG, H. (1992). Low serum cholesterol and suicide. The Lancet, 339, 727-729.
   PubMed Web of Science ®Google Scholar
• FREEMANTLE, N., HOUSE, A., SONG, F. et al. (1994). Prescribing selective serotonin reuptake inhibitors as a strategy for prevention of suicide. British Medical Journal, 309, 249-253.
   PubMed Web of Science ®Google Scholar
• GALLERANI, M., MANFREDI, R., CARACCIOLO, S. et al. (1995). Serum cholesterol concentrations in parasuicide. British Medical Journal, 310, 1632-1636.
   PubMed Web of Science ®Google Scholar
• HALLAS, J. (1996). Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology, 7, 478-484.
   PubMed Web of Science ®Google Scholar
• HAWTON, K., ARENSMAN, E., TOWNSEND, E. et al. (1998). Deliberate self harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventing depression. British Medical Journal, 317, 441-447.
   PubMed Web of Science ®Google Scholar
• HEALY, D. (1994). The fluoxetine and suicide controversy. CNS Drugs, 1, 223-231.
   PubMed Web of Science ®Google Scholar
• HEALY, D. & SAVAGE, M. (1998). Reserpine exhumed. British Journal of Psychiatry, 172, 376-378.
   PubMed Web of Science ®Google Scholar
• HEALY, D., LANGMAAK, C. & SAVAGE, M. (1999). Suicide in the course of depression. Journal of Psychopharmacology, 13, 94-99.
   PubMed Web of Science ®Google Scholar
• HENRY, J.A. & ANTAO, C.A. (1992). Suicide and fatal antidepressant poisoning. European Journal of Medicine, 1, 343-348.
   PubMedGoogle Scholar
• HENRY, J.A., ALEXANDER, C.A. & SENER, E.K. (1995). Relative mortality from overdose of antidepressants. British Medical Journal, 310, 221-224.
   PubMed Web of Science ®Google Scholar
• INSKIP, H.M., HARRIS, E.C. & BARRACLOUGH, B. (1998). Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. British Journal of Psychiatry, 172, 35-37.
   PubMed Web of Science ®Google Scholar
• ISACSSON, G., HOLMGREN, P., DRUID, H. et al. (1997). The utilisation of antidepressants a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994. Acta Psychiatrica Scandi-navica, 96, 94-100.
   PubMed Web of Science ®Google Scholar
• ISACSSON, G., HOLMGREN, P., DRUID, H. et al. (1999). Psycho-tropics and suicide prevention. Implications from toxicological screening of 5821 suicides in Sweden, 1992-1994. British Journal of Psychiatry, 174, 259-265.
   PubMed Web of Science ®Google Scholar
• ISACSSON, G., HOLMGREN, P., WASSERMAN, D. et al. (1994). Use of antidepressants among people committing suicide in Sweden. British Medical Journal, 308, 506-509.
   PubMed Web of Science ®Google Scholar
• JICK, S., DEAN, A.D. & JICK, H. (1995). Antidepressants and suicide. British Medical Journal, 310, 215-218.
   PubMed Web of Science ®Google Scholar
• JONAS, J.M. & HEARRON, A.E. (1996). Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression. Journal of Clinical Psychop-harmacology, 16, 208-211.
   PubMed Web of Science ®Google Scholar
• JOYCE, P., MULDER, R.T. & CLONINGER, C.R. (1994). Temperament predicts clomipramine and desipramine responses in major depression. Journal of Affective Disorders, 30, 35-46.
   PubMed Web of Science ®Google Scholar
• KAPUR, S., MIECZKOWSKI, T. & MANN, J.J. (1992). Antidepres-sant medications and the relative risk of suicide attempt and suicide. Journal of the American Medical Association, 268, 3441-3445.
   PubMed Web of Science ®Google Scholar
• KASPER, S. (1999). Treatment bene ts of reboxetine. International Journal of Psychiatry in Clinical Practice, 3, (Suppl. 1), S3 S8.
   Google Scholar
• KASPER, S., STAMENKOVIC, R. & FISCHER, G. (1995). Recurrent brief depression. Diagnosis, epidemiology and potential pharmacological options. CNS Drugs, 4, 222-229.
   Web of Science ®Google Scholar
• KELLEHER, M.J., DALY, M. & KELLEHER, M.J.A. (1992).The influence of antidepressants in overdose on the increased suicide rate in Ireland between 1971 and 1988. British Jour nal of Psychiatr y, 161, 625-628.
   PubMed Web of Science ®Google Scholar
• KING, R.A., RIDDLE, M.A., CHAPPELL, P.B. et al. (1991). Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. Journal of American Academic Child and Adolescent Psychiatry, 30, 171-176.
   Google Scholar
• LEON, A.C., KELLER, M.B., WARSHAW, M.G. et al. (1999). Prospective study of fluoxetine treatment and suicidal behaviour in affectively ill subjects. American Journal of Psychiatry, 156, 195-201.
   PubMed Web of Science ®Google Scholar
• LINDBERG, G., BINGEFORS, K., RANSTAM, J. et al. (1998). Use of calcium channel blockers and risk of suicide: ecological ndings con rmed in population based cohort study. British Medical Journal, 316, 741-745.
   PubMed Web of Science ®Google Scholar
• LIPINSKI, J.F., MALLYA, G., ZIMMERMAN, P. et al. (1989). Fluoxetine induced akathisia: clinical and theoretical implications. Journal of Clinical Psychiatry, 50, 339-342.
   PubMed Web of Science ®Google Scholar
• MEQUIES, L., JASSON, M., SOUBRIE, C. et al. (1998). Suicide prevention: the role of antidepressants. In: M. BRILEY & S. MONTGOMERY (Eds), Antidepressant therapy at the dawn of the third millennium (pp. 307-317. London: Martin Dunitz.
   Google Scholar
• MONTGOMERY, D.B., ROBERTS, A., GREEN, M. et al. (1994). Lack of efficacy of fluoxetine in recurrent brief depression and suicide attempts. European Archives of Psychiatry and Clinical Neurological Sciences, 244, 211-215.
   PubMed Web of Science ®Google Scholar
• MONTGOMERY, S.A. & BULLOCK, T. (1991). Do noradrena-line uptake inhibitors provoke suicide? In: H.Y. MELTZER & D. NEROZZI (Eds), Current practices and future developments in the pharmacotherapy of mental disorders (pp. 131-137. Amsterdam. Elsevier Science.
   Google Scholar
• MONTGOMERY, S.A., BULLOCK, T., BALDWIN, D.S. et al. (1992). The provocation and prevention of suicide attempts. International Clinical Psychopharmacology, 95 [Suppl.], S22 S34.
   Google Scholar
• MONTGOMERY, S.A., DUNNER, D.L. & DUNBAR, G.C. (1995). Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. European Neuropsychopharmacology, 5, 5-13.
   PubMed Web of Science ®Google Scholar
• MULDOON, M.F., MANUCK, S.B. & MATTHEWS, K.A. (1990). Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. British Medical Journal, 310, 309-314.
   Web of Science ®Google Scholar
• MULLER-OERLINGHAUSEN, B., AHREN, B., GROF, E. et al. (1992). The effects of long-term lithium treatment on the mortality of patients with manic-depressive and schizo-affective illness. Acta Psychiatrica Scandinavica, 86, 218-222.
   PubMed Web of Science ®Google Scholar
• MULLER-OERLINGHAUSEN, B., GROF, P. & SCHOU, M. (1999). Lithium and suicide prevention. British Jour nal of Psychiatry, 175, 90-91.
   PubMed Web of Science ®Google Scholar
• NAKIELNY, J. (1994).The fluoxetine and suicide controversy. A review of the evidence. CNS Drugs, 2, 252-253.
   Google Scholar
• PLOECKINGER, B., DANTENDORFER, K., ULM, M. et al. (1996). Rapid decrease of serum cholesterol concentration and postpartum depression. British Medical Journal, 313, 664.
   PubMed Web of Science ®Google Scholar
• ROTHSCHILD, A.J. & LOCKE, C.A. (1991). Re-exposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. Journal of Clinical Psychiatry, 52, 491-493.
   PubMed Web of Science ®Google Scholar
• ROUILLON, F., PHILLIPS, R., SERRURIER, D. et al. (1989). Rechutes de depression unipolaire et efficacite de la maprotiline, L’Encephale, 15, 527-534.
   PubMedGoogle Scholar
• SCHOU, M. (1998). The effect of prophylactic lithium treatment on mortality and suicidal behaviour: a review for clinicians. Journal of Affective Disorders, 50, 253-259.
   PubMed Web of Science ®Google Scholar
• SERFATY, M. & MASTERSON, G. (1993). Fatal poisonings attributed to benzodiazepines in Britain during the 1990s. British Journal of Psychiatry, 163, 386-393.
   PubMed Web of Science ®Google Scholar
• TEICHER, M.H., GLOD, C. & COLE, J.O. (1990). Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147, 207-210.
   PubMed Web of Science ®Google Scholar
• TEICHER, M.H., GLOD, C. & COLE, J.O. (1993). Antidepres-sant drugs and the emergence of suicidal tendencies. Drug Safety, 8, 186-212.
   PubMed Web of Science ®Google Scholar
• THIES-FLECHTNER, K., MULLER-OERLINGHAUSEN, B., SEIBERT, W. et al. (1996). Effect of prophylactic lithium treatment on suicide risk in patients with affective disorders: data from a randomised prospective study. Pharmacopsy-chiatry, 29, 103-107.
   PubMed Web of Science ®Google Scholar
• TOLLEFSON, G.D., GREIST, J.H., JEFFERSON, J.W. et al. (1994). Is baseline agitation a relative contra-indication for a SSRI: a comparative trial of fluoxetine versus imipramine. Journal of Clinical Psychopharmacology, 14, 385-391.
   PubMed Web of Science ®Google Scholar
• TONDO, L., JAMISON, K.R. & BALDESSARINI, R.U. (1997). Effect of lithium maintenance on suicidal behaviour in major mood disorders. Annals of the New York Academy of Sciences, 836, 339-351.
   PubMed Web of Science ®Google Scholar
• VERKES, R.J., VAN DER MAST, R.C., HENGEVELD, M.W. et al. (1998). Reduction by paroxetine of suicidal behaviour in patients with repeated suicide attempts but not major depression. American Journal of Psychiatry, 155, 543-547.
   PubMed Web of Science ®Google Scholar
• WARSHAW, M.G. & KELLER, M.B. (1996). The relationship between fluoxetine use and suicidal behaviour in 654 subjects with anxiety disorders. Journal of Clinical Psychiatry, 57, 158-166.
   PubMed Web of Science ®Google Scholar
• WICKHAM, B. & REED, J. (1987). Lithium for the control of aggressive and self-mutilating behaviour. International Clinical Psychopharmacology, 2, 181-190.
   PubMed Web of Science ®Google Scholar
• WIRSHING, W.C., VAN PUTTEN, T., ROSENBERG, J. et al. (1992). Fluoxetine, akathisia and suicidality: is there a causal connection? Archives of General Psychiatry, 49, 580-581.
   PubMed Web of Science ®Google Scholar
• WORLD HEALTH ORGANIZATION (1992). Health for all targets. The health policy for Europe.Summary of the updated edition. Copenhagen [EUR ICP HSC 013].
   Google Scholar
• ZUREIK, M., COURBON, D. & DUCIMETIERE, P. (1996). Serum cholesterol and death from suicide in men: Paris prospective study 1. British Medical Journal, 313, 649-651.
   PubMed Web of Science ®Google Scholar